Gilead Sciences announces executive departure in December

Gilead Sciences Inc. (NASDAQ: GILD) announced that Deborah H. Telman will step down from her role as Executive Vice President, Corporate Affairs and General Counsel effective December 5, 2025.

The company stated that Telman's employment will terminate later in December. The announcement was made on November 19, 2025, according to the press release.

The Delaware-based pharmaceutical company provided no additional details regarding the circumstances of the departure or plans for a replacement in the executive position.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• KKR reports over $750M in Q3 monetization activity
• Tempest Therapeutics (TPST) files for 9.53M share offering by selling stockholders